MedTrace Logo

Bone Marrow Aspirate Compared to Platelet Rich Plasma for Treating Knee Osteoarthritis

NCT03289416 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-04-20

Study results available
· View outcomes & findings →

Summary

This study is intended to compare whether bone marrow aspirate concentrate or platelet rich plasma injections is more effective in treating knee osteoarthritis.

Conditions

Interventions

COMBINATION_PRODUCT

Pure PRP II

The Pure PRP II system will be used to collect and concentrate blood into platelet rich plasma that will be injected into the knee.

COMBINATION_PRODUCT

PureBMC

The PureBMC system will be used to collect and concentrate bone marrow aspirate into bone marrow concentrate that will be injected into the knee.

Sponsors & Collaborators

  • EmCyte Corporation

    collaborator INDUSTRY

  • BioSciences Research Associates, Inc

    collaborator UNKNOWN

  • Andrews Research & Education Foundation

    lead OTHER

Principal Investigators

  • Joshua Hackel, MD · Andrews Institute for Orthopaedic & Sports Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-05
Primary Completion
2020-02-29
Completion
2020-02-29
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03289416 on ClinicalTrials.gov